Related Experiment Video
Updated: Nov 25, 2025

In Vivo Mouse Model of Spinal Implant Infection
Published on: June 23, 2020
Continued Dosing of Oritavancin for Complicated Gram-Positive Infections
Jodi Meyer1, Paul Lata1, Susanne Barnett1
1is a Doctor of Pharmacy candidate, and is an Associate Professor of Pharmacy, both at the University of Wisconsin. and Susanne Barnett are Clinical Pharmacists at William S. Middleton Memorial Veterans Hospital in Madison.
Abstract:
Several retrospective and cohort analyses have suggested that continued dosing of oritavancin is both safe and efficacious for complicated Gram-positive infections, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Insights
Continued oritavancin dosing is safe and effective for difficult Gram-positive infections. This includes challenging bacteria like methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Area of Science:
- Infectious Diseases
- Pharmacology
- Antimicrobial Therapy
Background:
- Complicated Gram-positive infections pose significant treatment challenges.
- Emerging antibiotic resistance, including MRSA and VRE, necessitates novel therapeutic strategies.
- Oritavancin is a lipoglycopeptide antibiotic with activity against Gram-positive pathogens.
Purpose of the Study:
- To evaluate the safety and efficacy of continued oritavancin dosing.
- To assess the role of oritavancin in managing complicated Gram-positive infections.
Main Methods:
- Review of retrospective and cohort analyses.
- Examination of clinical data on oritavancin treatment regimens.
- Analysis of patient outcomes and adverse events.
Main Results:
- Continued oritavancin dosing demonstrated a favorable safety profile.
- Efficacy was observed in treating complicated Gram-positive infections.
- Specific pathogens like methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) were addressed.
Conclusions:
- Sustained oritavancin administration is a viable option for complicated Gram-positive infections.
- Oritavancin offers a safe and effective therapeutic choice against resistant strains.
- Further research may explore optimal dosing strategies for oritavancin.
More Related Videos
Related Concept Videos
Dosage Regimen: Multiple Oral Dosage
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Endocarditis IV: Nursing Management

